After a grueling six-week-long contract negotiation, Ford and the United Auto Workers (UAW) have announced the establishment of a tentative labor deal, potentially signaling an
In a recent development, Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company focused on tackling severe diseases with substantial unmet needs, has confirmed the completion of
Sonoma Pharmaceuticals, a prominent global healthcare leader specializing in the development and production of patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products across various applications,
Eyecare technology trailblazer, Sight Sciences, has revealed its intent to unveil its financial performance for the third quarter ending September 30, 2023, subsequent to the
Bit Brother Limited, a diversified corporation with operations spanning business management in China and ventures in blockchain and cryptocurrency in the United States, experienced a
Shares of Mullen Automotive surged on Thursday, signaling a potential recovery following a prolonged period of adversity. The stock of Mullen Automotive, which had been
PaxMedica, a clinical-stage biopharmaceutical company, made a groundbreaking announcement today, declaring the successful completion of a type-B meeting with the US Food and Drug Administration
The European Central Bank (ECB) has decided to halt its relentless rate-hike program, which had pushed borrowing costs to historic highs over a 15-month period.
Stocks opened with little fanfare on Thursday, as investors paused to assess the aftermath of disappointing earnings reports from Big Tech giants and a surge